NCT07456436 Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
| NCT ID | NCT07456436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-11-26 |
| Primary Completion | 2026-11-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-11-26 with a primary completion date of 2026-11-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study assesses patient awareness and understanding of cancer clinical trials.
Eligibility Criteria
Inclusion Criteria: * Eligible patient participants will be: * Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported * Have been diagnosed any cancer type Exclusion Criteria: * Participants (patients) will be excluded if they: * Are unable to give informed consent * Are unable to speak English or Spanish
Contact & Investigator
Chanita Hughes-Halbert
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT07456436 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07456436 currently recruiting?
Yes, NCT07456436 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Southern California to inquire about joining.
Where is the NCT07456436 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07456436 clinical trial?
NCT07456436 is sponsored by University of Southern California. The principal investigator is Chanita Hughes-Halbert at University of Southern California. The trial plans to enroll 50 participants.